COVID-19 vaccine, Pfizer-BioNTech and Health Canada
Pfizer Canada and BioNTech Receive Health Canada Approval of Omicron KP.2 Variant Adapted COVID-19 Vaccine
Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX, "BioNTech") announced today that Health Canada has authorized the KP.2 variant adapted COMIRNATY® COVID-19 vaccine for ages 6 months and older. The updated COMIRNATY® vaccine targets the Omicron KP.
1don MSN
Premier Andrew Furey kicked off Newfoundland and Labrador's second well-being week on Monday, touting the province as ...
Epineuron continues to expand its clinical data through two ongoing trials, REGAIN™ and SELECT™, focused on nerve lacerations and compression injuries, respectively. With the regulatory approval ...
New agency will provide sustained focus on growing innovation and industrial capacity in the life sciences and biomanufacturing sector to support ...
Indigenous patients faced abuse, experimental treatments and other harms in Canada’s health system, which still has ...
It was not a coincidence that Canada’s ruling elite implemented what is in all essentials a program of social euthanasia in ...
Canada is donating up to 200,000 doses of the mpox vaccine to counter the global health emergency declared by the WHO. The ...
Research shows that health care plus opportunities create the best environment for refugee success in Canada. Not only does ...
For example, according to STAT: — Women in the U.S. have the lowest life expectancy and the highest rate of avoidable deaths.
Unions representing roughly 25,000 health-care support workers have issued a strike notice, alerting the province its members ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback